Salinas OS

Language: Spanish
References: 6
Page: 34-35
PDF size: 53.31 Kb.

ABSTRACT

The Metabolic Syndrome or Insulin Resistance Syndrome is nowadays and accepted and recognized clinical entity with a well defined clinical picture, its presence may be found in themost diverse clinical settings associated to hypertension, diabetes, dyslipidemia and obesity, it may also be found in young adults with coronary heart disease, where it may be the first important sign for a physician to suspect it and evaluate its influence over a highly accelerated atyherogenic process; we present a case who shows this characteristics and discuss the metabolic evaluation done to this patient.

REFERENCES

1. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1507.

2. Caro JF. Clin Rev 26: Insulin resistance in obese and nonobese man. J Clin Endoc Metab 1991; 73(4): 691-5.

3. Third report of the National Cholesterol Education Program (ncep) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult treatment panel III). NIH Publication No. 02-5215, 2002.

4. Tuomilehto J, Lindstrom J, Eriksson JG et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-50.

5. Shuldiner AR, Yang R, Gong DW. Resistin, obesity and insulin resistance. The emerging role of the adipocyte as an endocrine organ. N Eng J Med 2001; 345: 1345-6.

6. Yanovski SZ, Yanovski JA. Drug therapy: Obesity. N Engl J Med 2002; 346: 591-602.